CCAR2 and diffuse large B-cell lymphoma: analyzed 158 plasma samples from DLBCL patients and examined the DNA methylation patterns in the promoter regions for death-associated protein kinase 1 (DAPK1), deleted in breast cancer 1 (DBC1), MIR34A, and MIR34B/C using pyrosequencing (20).